METHOD FOR TREATING AND/OR PREVENTING REGNASE-1-RELATED DISEASE

SERUM RESPONSE FACTOR REGENERATES SENESCENT CELLS

USE OF MESENCEPHALIC ASTROCYTE-DERIVED NEUROTROPHIC FACTOR IN PREPARATION OF DRUG FOR TREATING HERPES SIMPLEX KERATITIS

PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES

EXTRACELLULAR VESICLES OR COMPOSITION THEREOF FOR USE AS A MEDICAMENT, SUCH AS FOR THE TREATMENT OF OCULAR SURFACE DISORDERS

Methods for Regulating Muscle Performance using Fat Specific Protein 27 (FSP27) Compositions

Methods of Diagnosing and Managing Bleeding Disorders

CHOLESTEROL-FREE HIGH-DENSITY LIPOPROTEIN PARTICLES

THERAPEUTIC TREATMENT OF SKIN DISEASE WITH RECOMBINANT COMMENSAL SKIN MICROORGANISMS

MATERIALS AND METHODS FOR SLC6A1 GENE THERAPY

Vectors for Increasing NPRL2 Expression in Cancer Cells and Methods of Use Thereof

MODULATORS OF THE G3BP2-TAU INTERACTION FOR THE TREATMENT OF TAU ASSOCIATED DISEASES

PEPTIDES AND METHODS OF TRANSPLANTATION AND RESTORATIVE ORGAN FUNCTION

Recombinant Protein For Inducing Cytoplasmic Vacuolization Cell Death And Use Thereof

DESIGNER EXTRACELLULAR VESICLES FOR TARGETED DELIVERY TO SCHWANN CELLS

BIOCOMPATIBLE DEVICES FOR CELL-BASED THERAPIES AND RELATED METHODS

METHODS AND COMPOSITIONS FOR DIRECT LINEAGE REPROGRAMMING OF ASTROCYTES TO OLIGODENDROCYTE LINEAGE CELLS

Magnetic-Assisted Nanoparticle Delivery and Gene Editing Systems and Methods of Use

ADMINISTRATION OF C5-BINDING PROTEINS

COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE

Systems and Methods for Angiogenic Treatment in Wound Healing

GENE PPARalpha FOR IMPROVING DISEASE RESISTANCE OF HALF-SMOOTH TONGUE SOLE CYNOGLOSSUS SEMILAEVIS AND USE THEREOF

COMPOSITION AND METHODS FOR TREATMENT OF PRIMARY CILIARY DYSKINESIA

USE OF TREM-1 INHIBITORS FOR TREATMENT, ELIMINATION AND ERADICATION OF HIV-1 INFECTION

AUF1 COMBINATION THERAPIES FOR TREATMENT OF MUSCLE DEGENERATIVE DISEASE

METHODS FOR UPREGULATING SHANK3 EXPRESSION

COMPOSITIONS AND METHODS TO PREVENT, INHIBIT OR TREAT NEURODEGENERATIVE DISEASES

PEPTIDE FORMULATIONS AND OPHTHALMIC USES THEREOF

COMPOSITIONS COMPRISING PEDF-DERIVED SHORT PEPTIDES (PDSP) AND USES THEREOF

CNS DELIVERY OF MRNA AND USES THEREOF

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF METABOLIC DISORDERS

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

PROPEPTIDE OF LYSYL OXIDASE FOR TREATMENT OF CANCER

COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF COMPLEMENT-RELATED DISORDERS

ASARM TREATMENT FOR KIDNEY AND MINERALIZATION DISORDERS AND HYPERPHOSPHATEMIA

ANGIOGENIC CONTROL, PREFERABLY COMBINED WITH GLYCAEMIC CONTROL

FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS

CATIONIC POLYMERS

MATERIALS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA

METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM CULTURED CELLS

Compositions and methods for treating non-age-associated hearing impairment in a human subject

CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS FOR THE TREATMENT AND PREVENTION OF SJÖGREN'S SYNDROME

GLUCOREGULATORY COMPOUND, COMPOSITION AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING CANCER AND ENHANCING IMMUNE CHECKPOINT INHIBITOR EFFICACY

COMPOSITIONS AND METHODS FOR LIVER-SPECIFIC EXPRESSION OF FOLLISTATIN

METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SPINAL CORD INJURY

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

FUSION PROTEIN BETWEEN SHORT FORM ROD-DERIVED CONE VIABILITY FACTOR AND A HYDROPHILIC PEPTIDE

PHARMACEUTICAL USE OF HYPOXIA-INDUCIBLE LIPID DROPLET-ASSOCIATED PROTEIN OR TRUNCATED FRAGMENT THEREOF

METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS

Methods of Improving Recovery After Lung Resection

GENE COMBINATION AS A BROAD SPECTRUM ANTIVIRAL

Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of NOS2, NOS3, VIP, KCNMA1, and CGRP genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-NOS2, or Escherichia coli strain SCS110-AF/VTvaf17-NOS3, or Escherichia coli strain SCS110-AF/VTvaf17-VIP, or Escherichia coli strain SCS110-AF/VTvaf17-KCNMA1, or Escherichia coli strain SCS110-AF/V

COMPOSITIONS AND METHODS FOR IMPROVED TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY

ANTICANCER PHARMACEUTICAL COMPOSITION CONTAINING IF1 AS ACTIVE INGREDIENT

rhApoE2 COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT METABOLIC DISEASE AND NEURODEGENERATIVE DISEASE

Probiotic method and composition for maintaining a healthy vaginal microbiome

METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST

BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE

NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS

COMPOSITIONS AND METHODS FOR ASSESSING AND TREATING AGE-RELATED CONDITIONS

TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY AND COMBINATIONS THEREOF

USE OF MECP2 AS BIOMARKER FOR DEPRESSION DIAGNOSIS AND DEPRESSION TREATMENT TARGET

ONCOSELECTIVE CANCER THERAPY

METHODS AND COMPOSITIONS FOR INHIBITING OXIDATIVE STRESS

SYSTEMS AND METHODS FOR DELIVERY OF HUMANIN OR OTHER PEPTIDES

CHAPERONES AS AN AUTOPHAGY RECEPTORS FOR CLEARANCES OF PROTEIN AGGREGATES AND/OR AGGREGATION-PRONE PROTEINS

PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION

Gene Therapy For Neurodegenerative Disorders

COMPOSITION FOR PREVENTING OR TREATING FIBROTIC DISEASES, COMPRISING HAPLN1

COMPOSITIONS AND METHODS FOR PREVENTION OF RETINAL NEURODEGENERATION

METHODS FOR TREATMENT OF NEURON DEGENERATION

CONSTRUCTS HAVING A SIRP-ALPHA DOMAIN OR VARIANT THEREOF

GENE THERAPY FOR TUBEROUS SCLEROSIS

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION

A SHORTENED P63-PROTEIN DOMAIN TO ENHANCE HUMAN CARDIAC REPROGRAMMING

Compositions and Methods for Treatment and Prevention of Misfolded Proteins

PEPTIDE HAVING OBESITY AND MUSCLE LOSS INHIBITORY ACTIVITIES, AND USE THEREOF

TREATMENT OF CANCERS OR NEOPLASMS BY INHIBITING KIF15

COMPOSITIONS AND METHODS FOR THE INDUCTION AND TUNING OF GENE EXPRESSION

TROPONIN C (TNNC1) GENE THERAPY USING AAV VECTOR

JUNCTOPHILIN-2 (JPH2) GENE THERAPY USING AAV VECTOR

THERAPEUTIC COMPOSITION FOR USE IN THE TREATMENT OF COVID-19 AND OTHER CYTOKINE STORM ASSOCIATED DISORDERS

AQP1 GENE THERAPY TO PREVENT RADIATION INDUCED SALIVARY HYPOFUNCTION

PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS

METHODS AND COMPOSITIONS FOR PKC-DELTA INHIBITION AND CANCER IMMUNOTHERAPY

TREATING DISEASES AND IMPROVING NUCLEIC ACID DELIVERY

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC CEREBROVASCULAR DISEASE

CONNEXIN 43 FOR USE IN THE TREATMENT OF RETINOBLASTOMA PROTEIN POSITIVE TUMOURS

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION

PHARMACEUTICAL COMPOSITION COMPRISING AN APL TYPE PEPTIDE

METHODS OF REDUCING NEUROPATHY AND NEUROPATHIC SYMPTOMS AND TREATING CANCER

COMPOSITION FOR PREVENTING OR TREATING SKELETAL MUSCLE DISEASE

ALK7 ANTAGONISTS AND USES THEREOF

USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

Methods and compositions for regenerating tissues

METHOD OF TREATING KNEE PAIN

LIQUID NUTRITIONAL COMPOSITION SUITABLE FOR MUSCLE FUNCTION

TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTR

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

Use of cell membrane-bound signaling factors

REGENERATIVE POLYPEPTIDES AND USES THEREOF

NUCLEIC ACID ENCODING GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS

Composition Comprising Trim31 and Rhbdf2 for Treatment of NAFLD/NASH

Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

REVERSAL OF CTL EXHAUSTION WITH ANNEXIN V

RECOMBINANT POLYPEPTIDES AND COMBINATIONS FOR USE IN THE TREATMENT OF CANCER

METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

Lipid Formulations for Delivery of Messenger RNA

ENGINEERED BIOMOLECULES FOR NUTRIENT REPROGRAMMING

NOVEL THERAPEUTIC PEPTIDES FOR NEURODEGENERATION

Method and system to modify an individual's gut-brain axis to provide neurocognitive protection

Extensive whey protein hydrolysate with tolerogenic peptides

Modulation of an Individual's Gut Microbiome to Address Osteoporosis and Bone Disease

COMPOSITIONS AND METHODS FOR TRANSGENE EXPRESSION

METHODS AND COMPOSITIONS FOR TREATING OCULAR DISEASES AND DISORDERS

Polynucleotide compositions, related formulations, and methods of use thereof

Gene therapy DNA vector based on gene therapy DNA vector VTvaf17 carrying the therapeutic gene selected from the group of ANG, ANGPT1, VEGFA, FGF1, HIF1a, HGF, SDF1, KLK4, PDGFC, PROK1, and PROK2 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain SCS110-AF/VTvaf17-ANG, or Escherichia coli strain SCS110-AF/VTvaf17-ANGPT1, or Escherichia coli strain SCS110-AF/VTvaf17-VEGFA, or Escherichia coli strain SCS110-AF/VTvaf17-FGF

ANTI-CITH3 ANTIBODIES AND USES THEREOF

Dry powder inhaler and system for drug delivery

GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING TRANSTHYRETIN (TTR) AND USES THEREOF

PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION

METHODS FOR REGULATING FREE FATTY ACID FLUX USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS

NUTRITIONAL COMPOSITION FOR IMPROVING INFANT MICROBIOTA

NOVEL TARGETS FOR ENHANCING ANTI-TUMOR IMMUNITY

Medicinal and Edible Dual-Purpose Composition Capable of Resisting Retinal Blue Light Damage, and Preparation Method and Application Thereof

CELL SPECIFIC GENE THERAPY DELIVERY COMPOSITIONS AND METHODS FOR TREATING HEARING LOSS

COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF METHYL-CPG BINDING PROTEIN 2 (MECP2)

GENE THERAPY CONSTRUCTS AND METHODS FOR TREATMENT OF HEARING LOSS

COMPOSITION FOR INHIBITING ALPHA-SYNUCLEIN AGGREGATION AND METHOD FOR INHIBITING ALPHA-SYNUCLEIN AGGREGATION

SYNTHETIC EXOSOMES (SE) FOR CNS DELIVERY OF CRISPR FOR GENE EDITING IN BRAIN DISORDERS

AGENT FOR ENHANCING PHAGOCYTOSIS ABILITY OF NEUTROPHILS

COMPOSITION FOR PREVENTING OR TREATING VASCULAR DISEASES, CONTAINING HAPLN1

TREATMENT AND DIAGNOSIS OF MELANOMA

CHIMERIC PROTEINS AND METHODS OF USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

SMAD7 POLYPEPTIDE FORMULATIONS

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE

CANCER TREATMENT BY TARGETING PROTEINS OR INTERACTIONS OF EPHRINB-RGS3-KIF20A-SEPT7 AXIS

INHIBITORS AND USES THEREOF

METHODS AND COMPOSITIONS FOR MODULATING APPETITE AND INTAKE OF SODIUM

FERRITIN COMPOSITION TOLERABILITY

COMPOSITIONS AND METHODS FOR TREATING ALLERGIES AND INFLAMMATORY CONDITIONS

NF-KB AS BIOMARKER FOR ASSESSING TREATMENT EFFICACY IN PARKINSON'S DISEASE

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED THERAPEUTIC AGENTS

WNT5A PEPTIDES FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA

COMPOSITION COMPRISING ZAG-DERIVED PEPTIDE FOR IMPROVING SCARS AND KELOIDS

PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS

PREVENTION AND TREATMENT OF CHEMOTHERAPY-INDUCED NEUROPATHIC PAIN

GENE THERAPY FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA

INTRAMUSCULAR COMPOSITIONS OF BOTULINUM NEUROTOXINS

ENHANCED EFFICACY OF TOLEROGENIC VACCINATION

DOSAGE REGIME FOR APOLIPOPROTEIN FORMULATIONS

COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta

G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD)

INHIBITION OF BETA-ARRESTIN OLIGOMERIZATION IN TAUOPATHY

METHODS OF TREATING SICKLE CELL DISORDER AND RELATED CONDITIONS

RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION

COMPOSITIONS AND METHODS FOR MODULATING MAMMARY DISORDERS AND CONDITIONS

CHACTERIZATION OF BIOLOGICAL ACTIVITY OF FERRITIN PROTEIN BY MASS PRODUCTION USING THE RECOMBINANT VECTOR

COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIVE DISORDERS

METHODS AND MATERIALS FOR TREATING A STROKE

USE OF EXTENSIVELY HYDROLYSED PROTEIN

POLYPEPTIDE FOR USE IN THE PROTECTION OF OXYGEN SENSITIVE GRAM-POSITIVE BACTERIA

IL-18 Binding Protein (IL-18BP) and Antibodies for Treating Inflammatory Diseases

Recombinant Adeno-Associated Virus Encoding Methyl-CPG Binding Protein 2 for Treating PITT Hopkins Syndrome VIA Intrathecal Delivery

DNA STRUCTURE FOR TREATING OCULAR PATHOLOGIES

MEDICATION FOR TREATING LUNG INJURY

MODULATION OF IFI16 AND STING ACTIVITY

IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER

Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas Fusion Protein and Methods of Treatment

COMPOSITIONS AND METHODS OF USE FOR SECRETOGLOBINS TO PROTECT THE GLYCOCALYX VIA INTERACTIONS WITH HEPARAN SULFATE PROTEOGLYCAN PROTEINS

HUMAN PLURIPOTENT STEM CELL-DERIVED SECRETOME AS A BIOLOGIC FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE AND APOPTOTIC DISEASES

BASE EDITING FOR TREATING HUTCHINSON-GILFORD PROGERIA SYNDROME

METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS BY SUPPRESION OF TRANSCRIPTION FACTORS

PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS

METHODS AND COMPOSITIONS FOR REJUVENATING CNS GLIAL POPULATIONS WITH BCL11A TRANSCRIPTION FACTOR EXPRESSION

PROX1 PREVENTS MYXOMATOUS VALVE DISEASE BY INHIBITING PDGF-B SIGNALING

OPTOGENETIC VISUAL RESTORATION USING CHRIMSON

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

METHODS OF TREATING NEURODEGENERATIVE DISORDERS WITH INTRANASAL NF-KAPPAB ESSENTIAL MODIFIER (NEMO)-BINDING DOMAIN (NBD) PEPTIDE

GAL3BP POLYPEPTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER AND DETERMINING TREATMENT RESPONSIVENESS

Systems and methods for delivery of humanin or other peptides

COMPOSITION FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS

Topical application to treat acne vulgaris

MATERIALS AND METHODS FOR MODULATING T CELL MEDIATED IMMUNITY

Compositions comprising an urolithin compound

Activin receptor type IIB variants and methods of use thereof

METHOD TO ENHANCE THE EFFICIENCY OF SYSTEMIC AAV GENE DELIVERY TO THE CENTRAL NERVOUS SYSTEM

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS

METHOD FOR REPAIRING SERTOLI CELL INJURY IN TESTES

USE OF ENHANCED TBX1 EXPRESSION IN REPAIRING HEART TISSUE INJURY

PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS

Methods of Treating Human X-Linked Retinoschisis Using Gene Therapy

Dual-Mode Pharmaceutical Composition for Peptide-Specific Targeted Positron Emission Tomography and Boron Neutron Capture Therapy and the Use Thereof

APOMERS

LIPOPEPTIDES FOR USE IN TREATING LIVER DISEASES AND CARDIOVASCULAR DISEASES

REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE

PROCESS OF MANUFACTURE OF ANNEXIN V

DPEP-1 Binding Compositions and Methods of Use

Method of Treating Corneal Opacities and Scarring

AN ANTIBODY FRAGMENT BASED ANTIFUNGAL CONJUGATE SELECTIVELY TARGETING CANDIDA

ENGINEERED SIRPa VARIANTS AND METHODS OF USE THEREOF

REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEURAL INJURY CAUSED BY DISRUPTION OF BLOOD FLOW

COMPOSITIONS FOR AND METHODS OF IMPROVING FLUID FLUX IN THE BRAIN

LgRNA-directed CRISPR Gene Editing

Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof

COCHLEAR OUTER HAIR CELL REGENERATED BY ECTOPIC JOINT OVEREXPRESSION OF ATOH1 AND IKZF2 AND APPLICATION THEREOF

THERAPEUTIC PEPTIDES

Compositions and methods for treating cancer

NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS

PROCESS AND COMPOSITION MATTER OF NANOPARTICLE FORMULATION FOR SYSTEMIC TREATMENT OF SEPSIS

ENHANCING MITOCHONDRIAL-BASED FLOW AND CATABOLISM OF CHOLESTEROL

METHOD FOR INDUCING RESOLUTIVE MACROPHAGE AND USES THEROF

COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH sHDL NANOPARTICLES

COMPOSITIONS FOR TREATING FRIEDREICH'S ATAXIA

GENE THERAPY FOR TREATING USHER SYNDROME

METHODS FOR ACTIVATING IMMUNE CELLS AND TREATING OCULAR NEOVASCULARIZATION

METHOD OF INDUCING CARDIOMYOCYTES PROLIFERATION AND TREATING HEART DISEASES

GENE THERAPY COMPOSITION AND TREATMENT OF RIGHT VENTRICULAR ARRHYTHMOGENIC CARDIOMYOPATHY

ANNEXIN A1 N-TERMINAL PEPTIDE FORMULATIONS AND METHODS

PRODRUG COMPRISING A DRUG LINKER CONJUGATE

USE OF REGULATOR OF ITPRIPL1 IN PREPARATION OF DRUG THAT REGULATES IMMUNE RESPONSES OR FIGHTS TUMORS

TYPE I DIABETES THERAPY

Gene Therapy For Neurodegenerative Disorders

METHODS FOR TREATING ACUTE CONDITIONS USING LIPID BINDING PROTEIN-BASED COMPLEXES

PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOME

NOVEL COMPOSITIONS WITH TISSUE-SPECIFIC TARGETING MOTIFS AND COMPOSITIONS CONTAINING SAME

PERSONALIZED FUSION CELL VACCINES

IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY

USE OF CYP4V2 AND RDCVF IN THE MANUFACTURE OF MEDICAMENT

Heparin-Associated Polypeptides and Uses Thereof

Pharmaceutical composition for treating, preventing or ameliorating spinal muscular atrophy and administration method thereof

Method and system to modify an individual's gut-brain axis to provide neurocognitive protection

Method and system for modulating an individual's skin microbiome

CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS

LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF

SONOGENIC STIMULATION OF CELLS

COMPOSITIONS AND METHODS FOR TREATING MOTOR NEURON DISEASES

Wound Healing Promoting Protein

BYSTANDER PROTEIN VACCINES

Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH

TREATMENT FOR GINGIVITIS

Compositions and methods for treating non-age-associated hearing impairment in a human subject

METHODS, SYSTEMS, AND COMPOSITIONS FOR LEGUME-BASED PRODUCTION OF THERAPEUTIC PROTEINS AND THERAPEUTIC MEDICAL MATERIALS

METHODS OF TREATING METASTATIC CANCERS USING AXL DECOY RECEPTORS

MACROPHAGE ACTIVATOR

FRATAXIN EXPRESSION CONSTRUCTS

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

Lipoprotein complexes and manufacturing and uses thereof

Compositions and Methods for Treating Spinal Muscular Atrophy

PRION-FC REGION FUSION PROTEIN AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE

MUTANT NGAL PROTEINS AND USES THEREOF

Compositions and methods for treating non-age-associated hearing impairment in a human subject

PREVENTION AND/OR TREATMENT OF HEARING LOSS OR IMPAIRMENT

USE OF PHOSPHATIDYLSERINE IN PREPARATION OF DRUG FOR TREATING INFLAMMATORY BOWEL DISEASE

Optimized mini-dystrophin genes and expression cassettes and their use

COMPOSITION DERIVED FROM MAMMALIAN UMBILICAL CORD AND WHARTONS JELLY FOR USE IN THERAPEUTIC AND REGENERATIVE APPLICATIONS

DIAGNOSTIC AND THERAPY OF TRAUMATIC BRAIN INJURY

Methods for treating an ocular condition with cellular fibronectin compositions

USE OF REELIN FOR TREATING CARDIAC DISEASES

METHOD FOR ALLEVIATING DEPRESSION USING TNFAIP3-INTERACTING PROTEIN (TNIP) 1

ISCHEMIA/REPERFUSION INJURY

Probiotic method and composition for maintaining a healthy vaginal microbiome

Reelin/VEGF-C production/activation promoter and skin external composition using the same

METHODS FOR TREATMENT OF AND PROPHYLAXIS AGAINST INFLAMMATORY DISORDERS

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT

Lipoprotein complexes and manufacturing and uses thereof

IMPROVED PROCESS AND FORMULATION OF LIPID NANOPARTICLES

USE OF THE SESTRIN2 FOR THE TREATMENT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY

METHODS OF TREATING LYMPHOPENIA

Use of CDK Inhibitors to Enhance Growth and Self-Renewal of Progenitor Cells

ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS

Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells

METHODS FOR TREATING COVID-19

Methods of altering bone growth by administration of Sost or Wise antagonist or agonist

VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS TREATMENT AND PREVENTION

COMPOSITION FOR DIAGNOSING, PREVENTING, OR TREATING COGNITIVE DYSFUNCTION COMPRISING COTL1 AS ACTIVE INGREDIENT

Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

Permanent Epigenetic Gene Silencing

Composition for Inducing Direct Cross Differentiation of Somatic Cell into Motor Neuron, and Method for Using Same

THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS

Methods of Treating Human X-Linked Retinoschisis Using Gene Therapy

PLASMID VECTORS AND NANOPARTICLES FOR TREATING OCULAR DISORDERS

CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION

METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS

COMPOSITIONS AND METHODS COMPRISING R-SPONDINS FOR TREATMENT OF TUMORS

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

ANTIVIRAL COMPOSITIONS AND METHODS

VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY

COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES

NUCLEIC ACID THERAPY FOR DIFFERENTIAL MODULATION OF HOST MICROFLORA